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The administration of antimeningococcic serum for the treatment of 
epidemic meningitis by other than  the intraspinal  route has hardly 
been considered until recently, since the publication of the papers by 
Flexner and his coworkers  I .~ on the specific serum therapy of the dis- 
ease on which the prevailing mode of treatment is  based.  The ex- 
perience with a  large number of cases of epidemic meningitis during 
the great war and under the unusual conditions of camp life has led 
to the revival of the employment of the serum by intravenous,usually 
associated  with  intraspinal,  injection.  That  the  intravenous  ad- 
ministration was  both  indicated and  called for is  evidenced by  the 
occurrence of cases of meningococcemia in  some instances without, 
and in others before the onset of, the meningitis? ,4  Although other 
clinicians have from time to time employed antimeningococcic serum 
by intravenous injection the systematic use of it in that manner has 
been developed especially by Herrick. 
The  purpose  of  the  intravenous  injection  may  be  regarded  as 
threefold: (1)  to combat the meningococcemia; (2)  to  diminish pos- 
sibly the rapidity of the passage of the serum from the subarachnoid 
space into the blood; and (3) to bring remote portions of the meninges, 
not so readily accessible from the spinal fluid itself, under the influ- 
1 Flexner, S., J. Am. Med. Assn., 1906, xlvii, 560; J. Exp. Med., 1917, ix, 168; 
1913, xvii, 553. 
2 Flexner, S., and Jobling, J. W., J. Exp. Med., 1908, x, 141,690. 
3 Herrick, W. W., J. Am. Med.  Assn.,  1918,  lxxi,  62; Arch.  Int. Med.,  1918, 
xxi, 541. 
4 Baeslack,  F.  W.,  Bunce, A.  H.,  Brunelle,  G.  C.,  Fleming, J.  S.,  Klugh,  G. 
F., McLean, E. H., and Salomon, A. V., J. Am. Med. Assn., 1918, lxx, 684. 
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ence of the serum.  Under normal conditions antibodies do not pass 
from the blood into the cerebrospinal fluid,  5 but under circumstances 
of inflammation of the meninges the permeability is increased, and 
passage may in some degree take place.  Of the three possibilities, 
the first, namely the control of the blood invasion by meuingococci, 
may be regarded as the most important, since it may, if only in rare 
instances, prevent or abort a meningeal infection, and it may be even 
more effective in preventing the infections of  joints, heart, eye, etc. 
The experiments  to  be  described  relate  to  the  question  of  the 
possibility and the degree of passage of antibodies, in this instance 
agglutinins, for the meningococcus from the blood into the cerebro- 
spinal fluid. 
EXPERIM-ENTAL. 
Macacus  rhesus  monkeys were employed for the experiments be- 
cause of the ease with which chemical meningitis may be induced in 
them and especially because they readily yield cerebrospinal fluid on 
lumbar puncture. 
The first experiment was arranged to test two points: (a)  whether 
the  antimeningococcus agglutinins passed  from the  blood into  the 
cerebrosplnal fluid in normal animals, and  (b)  whether they passed 
in animals in which a chemical meningitis had been incited when only 
10  cc.  of  the  antiserum had been injected into  a  superficial vein. 
The protocol which follows shows not only that no such passage takes 
place in the normal animal but either none that is demonstrable, or 
at least very little, even in the presence of an aseptic meningitis. 
Experiment  /.--Mar.  13,  1918.  Three  Macacus  rhesus  monkeys,  weighing 
about 3 kilos each, received intravenously 10 cc. of polyvalent antimeningococclc 
serum.  Monkeys A  and  B  had  received  18  hours previously  2  cc.  of normal 
horse  serum intraspinally.  No intraspinal  injection  was  given Monkey  C.  7 
and 24 hours after the intravenous injection spinal fluid was removed from each 
and tested for agglutination against the meningococcus.  None was observed in 
either specimen from the monkey which received no intraspinal injection.  The 
same  was  true  of the  specimens  from one of the  monkeys in  which  chemical 
meningitis had been induced.  The spinal fluid removed 7 hours but not 24 hours 
after intravenous injection from the second monkey, which had received intra- 
spinal injection of horse serum, agglutinated regular and parameningococcus in a 
dilution of 1:2 and 1: 4. 
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The second experiment was  made with  20  cc.  of polyvalent anti- 
meningococcic serum of high titer which was injected in each instance 
into a  superficial vein.  It was devised to cover the following condi- 
tions:  (a)  effect on normal cerebrospinal fluid,  (b)  effect on cerebro- 
spinal fluid modified by a  mild aseptic meningitis induced by an in- 
traspinal  injection  of  sterile  normal  salt  solution,  (c)  effect on  the 
cerebrospinal fluid modified by a  more severe chemical inflammation 
induced by normal horse serum, and (d) a  still more severe inflamma- 
tion brought  about by the injection of a  salt solution suspension of 
regular  meningococcus  culture.  In  the  last  instance  the  agglutinin 
tested for was that of the para organism. 
The  result  is  clear:  no  agglutinins  were  present  in  the  cerebro- 
spinal fluid derived from the normal animal which received the intra- 
venous  injection;  fluctuating  amounts  were  present  in  the  cerebro- 
spinal fluid after salt solution, more after the horse serum injection, 
and  most  after  the  injection  of  meuingococcus.  In  other  words, 
the  normal meninges were not permeable, while  the inflamed mem- 
branes  were  permeable  in  proportion  to  the  intensity  of  the  men- 
ingitis experimentally induced. 
Experiment 2.--Macacus  rhesus D, weight 3.2 kilos;  control.  Mar. 21, 1918. 
Injected intravenously 20 co. of polyvalent antimeningococcic  serum.  5.25  p.m. 
Lumbar puncture,  0.5  co. of clear fluid which  did not agglutinate  regular or 
parameningococcus.  Mar.  22,  10.10 a.m.  Lumbar  puncture,  1  cc.  of clear 
fluid which did not agglutinate the meningococci.  5.50 p.m.  Injected intraspin- 
ally one-quarter of an 8 hour culture of regular meningococcus in 0.5 co. of iso- 
tonic salt solution.  Mar.  23,  12 m.  Lumbar puncture, 0.5 cc. of turbid fluid 
which,  after centrifugation, agglutinated parameningococcus  ++  in a  dilution 
of  I: 4.  Culture  from  spinal  fluid  negativ¢.  Mar.  24,  10.35 a.m.  Lumbar 
puncture, 0.5 cc. of turbid fluid.  Cultures negative.  Centrifuged fluid  agglu- 
tinated parameningococcus  +  in a dilution of 1: 2. 
Macacus rhesus E, weight 3.5 kilos.  Mar.  20,  1918, 4 p.m.  Injected intra- 
spinally  2  cc.  of isotonic salt  solution.  Mar.  21,  11.10 a.m.  Injected intra- 
venously 20 cc.  of polyvalent antimeningococcic  serum.  Mar.  22,  10.30 a.m. 
Lumbar puncture,  1 cc. of slightly turbid fluid.  The centrifuged fluid did not 
agglutinate regular or parameningococcus  in a dilution of 1: 2.  5.45 p.m.  In- 
jected intraspinaUy one-quarter of an 8 hour culture of regular meningococcus in 
0.5 cc. of isotonic salt solution.  Mar. 23, 11 a.m.  Lumbar puncture, 0.5 cc. of 
turbid fluid which yielded negative culture.  The centrifuged fluid agglutinated 
parameningococcus  +  in a dilution of 1: 4.  Mar, 24, 10.25 a.m.  Lumbar punc- 600  PASSAGE  OF  MENINGOCOCCIC  AGGLUTININS 
ture, 0.5 cc. of slightly turbid fluid which yielded negative culture.  The centri- 
fuged fluid agglutinated parameningococcus  + +  in a dilution of 1: 4. 
Macacus rhesus F, weight 3.3 kilos.  Mar.  20,  1918, 4 p.m.  Injected intra- 
spinally  2 cc. of normal horse serum.  Mar. 21,  10.38 a.m.  Injected intraven- 
ously  20  cc.  of  polyvalent  antimeningococcic  serum.  Mar.  22~  10.20 a.m. 
Lumbar puncture, 0.5 cc. of turbid spinal  fluid.  The centrifuged  fluid agglu- 
tinated regular  meningococcus  ~-  1: 4,  -  1: 2, and parameningococcus  +  1 : 4 
and  -  I: 2.  6.15 p.m.  Lumbar puncture, 0.5 cc. of turbid fluid which after 
centrifuging agglutinated parameningococcus +  1: 4.  Injected intraspinally one- 
fourth of an 8 hour culture of regular  meningococcus in 0.5 cc. of isotonic salt 
solution.  Mar. 23,  11.30 a.m.  Lumbar puncture, 0.5 cc. of turbid fluid; cul- 
ture negative;  the centrifuged  fluid agglutinated regular  meningococcus +  in a 
dilution of 1: 2,  ++  1: 4, and parameningococcus  +  1: 2,  -  I: 4. 
The  next experiment brings  out conclusively the  effect of  degree 
of chemical inflammation in promoting the passage of agglutinating 
bodies from the blood into the spinal fluid.  The order of the experi- 
ment was first to inject intraspinally into  Macacus  rhesus  monkeys 
either isotonic salt solution or normal horse serum, and about 20 hours 
later  to  give  20  cc.  of  polyvalent  antimeningococcic  serum  intra- 
venously.  The spinal fluid is then withdrawn at stated intervals and 
tested.  When salt solution or horse serum is injected intraspinally 
and the turbid fluid withdrawn later and tested for agglutinins of the 
meningococcus no agglutination takes place unless antimeningococcic 
serum has been given also.  The results of this experiment are given 
in Table I.  The far greater effect of the horse serum over isotonic 
salt solution is at once apparent. 
Attention  has  been  drawn  to  the  practice  now  becoming  more 
common of combining the intravenous with the intraspinal injection 
of  the  antimeningococcic  serram.  Time  and  experience  alone  will 
decide in how far this practice is superior to the intraspinal injection 
alone.  The  serum  introduced  into  the  subarachnoid  space  soon 
begins  to escape into  the blood; hence the necessity for its  reintro- 
duction if the meninges are to be kept bathed in the antiserum.  The 
passage of the antiserum from the subarachnoid space into the blood 
leads to a  general distribution throughout the organs.  Possibly the 
higher dilution thus produced compared with the greater concentra- 
tion secured from a direct injection of the larger volume of serum into 
the blood gives to the latter  a  special  advantage in overcoming the 
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It  seemed  desirable  to  determine, by  direct  agglutination  tests, 
the agglutination titer of the blood and spinal fluid under the three 
sets of conditions; namely, after an intraspinal injection alone, after 
an intravenous injection alone,  and  after  combined intraspinal  and 
intravenous  injection.  This  determination  was  made in  monkeys; 
it could of course be carried out better with cases of epidemic men- 
ingitis under serum treatment.  Unfortunately we were restricted by 
the  scarcity  of monkeys to one test  of each  condition.  The result 
given in Text-fig.  1, a, b,  and c must be regarded, therefore, as ten- 
tative  only.  Certain  factors  affecting  the  results  are  entirely  ob- 
TABLE  I. 
Intraspinal  in~ect~on. 
Isotonic salt solution. 
Normal horse serum. 
Length  of time 
after 
intravenous 
injection. 
Dilutions  of spinal fluid. 
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scure;  such,  for  example,  as  the  delay  after  intravenous  injection 
before  the  full  expression  of  the  agglutination  titer  declares  itself. 
The  three  curves  are,  however,  not  only  distinct,  but  suggest  first 
that passage of the serum from the cerebrospinal fluid into the blood 
begins almost at once (Text-fig. 1, a), and second that the persistence 
of the titer  in the blood and  spinal fluid  (Text-fig.  1,  c)  is sensibly 
affected by combined  intraspinal  and  intravenous  injection.  How- 
ever,  we  desire  to  repeat  that  not  too much  stress  should  be  laid 
upon the results of these single tests. 
Experiment  3.--Macacus  rhesus  G.  May 14,  1918, 9.15 a.m.  Injected in- 
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agglutination  tests  at  10.30  a.m.,  1.15,  5.15,  and 9.30  p.m.  Lumbar puncture 
at  10.50 a.m.,  1.25, 5.45,  and 9.45 p.m.  May 15.  Bleedings at  10.45 a.m. and 
4.18  p.m.  Lumbar puncture  at  10.50  a.m.  and  4.23  p.m.  The  samples  were 
tested  May  16  for agglutinins  with  a  parameningococcus,  and  the  results  are 
recorded in Text-fig.  1, a. 
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Meningococcic agglutinins in the spinal fluid. 
T~xr-FIc.  1,  a,  b,  and  c.  (a)  Meningococcic agglutinins  in  the  blood  and 
spinal fluid of the monkey after intraspinal injection of 3 cc. of antimeningococcic 
serum.  (b)  Meningococcic  agglutinins  in  the  blood  and  spinal  fluid  of  the 
monkey after  intravenous  injection  of antimeningococcic serum and  the intra- 
spinal  injection  of normal  horse  serum.  (c)  Meningococcic agglutinins  in  the 
blood and spinal fluid of the monkey after combined intravenous and intraspinal 
injection of antimeningococcic serum. HAROLD  L.  AMOSS AND  FREDERICK  EBERSON  603 
Macacus  rhesus  H.  May  13,  1918,  5  p.m.  Injected intraspinaUy 2  cc.  of 
normal horse serum.  May 14, 8.10 a.m.  Injected intravenously 20 cc. of poly- 
valent  antimeningococcic  serum.  Specimens  of  spinal  fluid  and  blood  were 
taken at 9.10 a.m.,  12.10  and 8.10 p.m., and at 9.10 a.m. on May 15.  The re- 
sults of the agglutination tests with parameningococcus on May 16 are recorded 
in Text-fig. 1, b. 
Macacus  rhesus  I.  May  14,  1918,  9.30  a.m.  Injected intraspinally 3  cc. 
and  intravenously  20  cc.  of polyvalent antimeningococcic serum.  Samples of 
blood and spinal fluid were removed at 11 a.m., 1.30,  6, and 9.40 p.m.  May 15. 
Specimens taken at 10.50 a.m. and 4.25  p.m.  The results of  agglutination tests 
with parameningococcus on May 16 are shown in Text-fig. 1, c. 
CONCLUSIONS. 
Agglutinins for  the meningococcus were not found in  the spinal 
fluid  of  normal  monkeys  which  had  received  antimeningococcic 
serum intravenously. 
The  intraspinal  injection of  isotonic salt  solution,  normal horse 
serum, or a  culture of living meningococci allows agglutinins for the 
meningococcus to pass from the blood to the spinal fluid of the pas- 
sively immunized monkey; and the rate of the passage is affected by 
the severity of the inflammation induced in the meninges. 
The rates of elimination from the blood and spinal canal of menin- 
gococcic antibodies, as shown by the agglutination reaction, were com- 
pared in monkeys treated with immune serum (a) intraspinally, (b) in- 
travenously, and (c) intraspinally and intravenously in combination. 
(a)  When immune serum is given intraspinally the agglutinins are 
very much diminished after 8 hours and practically disappear at 12 
hours.  They appear in the blood at the 4th hour after injection and 
quickly diminish. 
(b)  After intravenous injection of immune serum, when the men- 
inges  are  inflamed,  agglutinins appear  in  the  spinal fluid in  small 
amounts in  about  12  hours and increase to  the 25th hour.  More 
than one-half of the agglutinins disappear from the blood within 8 
hours and remain in low concentration at 25 hours. 
(c)  After  combined  intraspinal  and  intravenous  injection  the 
agglutinins remain in higher concentration in the spinal fluid and for 
a longer time than by method (a)  or (b).  The curve descends after 
12 hours, and agglutinins are present at 25 hours.  They remain in 
maximum concentration in the blood for 25 hours. 